- Home
- STXS vs TVGN Comparison
STXS vs TVGN Comparison
Compare STXS & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STXS | TVGN |
|---|---|---|
| Founded | 1990 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.6M | 63.9M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | STXS | TVGN |
|---|---|---|
| Price | $1.81 | $5.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 399.7K | ★ 439.7K |
| Earning Date | 03-09-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,346,617.00 | N/A |
| Revenue This Year | $34.08 | N/A |
| Revenue Next Year | $35.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.54 | $0.14 |
| 52 Week High | $3.59 | $10.76 |
Technical Indicators
Market Signals| Indicator | STXS | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 32.06 | 64.60 |
| Support Level | N/A | $0.53 |
| Resistance Level | $2.52 | $10.76 |
| Average True Range (ATR) | 0.12 | 0.91 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 10.74 | 47.16 |
Price Performance
Historical ComparisonAbout STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.